Загрузка...
Mesenchymal stem cells-bridge catalyst between innate and adaptive immunity in COVID 19
Majority of patients infected with the COVID 19 virus display a mild to moderate course of disease and spontaneously recover at 14–20 days. However, about 15% of patients progress to severe stages and 2.5% of these patients succumb to this illness. Most patients with severe disease belong to the eld...
Сохранить в:
| Опубликовано в: : | Med Hypotheses |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Published by Elsevier Ltd.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7232064/ https://ncbi.nlm.nih.gov/pubmed/32425307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mehy.2020.109845 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|